Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Myasthenia Gravis × Sugars × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 12 cyclopia sequence 7 Neoplasms 4 Polycystic Ovary Syndrome 3 Multiple Myeloma 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Vomiting 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pain 2 Neoplasms, Plasma Cell 2 Nausea 2 Leiomyoma 2 Hematologic Diseases 2 Head and Neck Neoplasms 2 Depression 2 Weight Loss 1 Warts 1 Urinary Bladder Neoplasms 1 Testicular Neoplasms 1 Sleepiness 1 Sezary Syndrome 1 Prostatic Intraepithelial Neoplasia 1 Primary Myelofibrosis 1 Peripheral Nervous System Diseases 1 Pediatric Crohn's disease 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Parasomnias 1 Papilloma 1

Interventions

rozanolixizumab 4 eculizumab 4 zilucoplan 3 efgartigimod alfa 3 Rituximab 2 Prednisone 2 Amifampridine 2 thymoglobulin 1 satralizumab 1 rhoA GTP-Binding Protein 1 ravulizumab 1 inebilizumab 1 gamma-Globulins 1 Thymectomy 1 Sugars 1 Steroids 1 Sodium Chloride 1 Robotic Surgical Procedures 1 Prednisolone 1 Methylprednisolone 1 Methotrexate 1 Mesna 1 Hizentra 1 Hematopoietic Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1 Fluid Therapy 1 Cyclophosphamide 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00995722 2017-06-02

EPITOME'

University of Miami

Phase 3 Terminated

11 enrolled 14 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡